Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-25 @ 4:54 AM
Ignite Modification Date:
2025-12-26 @ 3:54 AM
NCT ID:
NCT02021318
Pre Assignment Details:
Participants were randomized in a 1:1 ratio to roxadustat or darbepoetin alfa. Randomization was stratified by 4 factors: region, screening hemoglobin (Hb) values (Hb ≤ 8.0 g/dL versus \> 8.0 g/dL), history of cardiovascular, cerebrovascular or thromboembolic diseases and screening eGFR (\<30 mL/min/1.73 m\^2 versus ≥30 mL/min/1.73 m\^2 ).
Recruitment Details:
Participants of ≥ 18 years of age with a diagnosis of chronic kidney disease, with kidney disease outcomes quality initiative stage 3, 4 or 5, anaemic and not receiving dialysis; with an estimated glomerular filtration rate (eGFR) \< 60 milliliter per minute per 1.73 meter square (mL/min/1.73 m\^2) were enrolled in this study.
Study:
NCT02021318
Study Brief:
Results Section:
NCT02021318